Inhibiting Cycloxygenase and Ornithine Decarboxylase by Diclofenac and Alpha-Difluoromethylornithine Blocks Cutaneous SCCs by Targeting Akt-ERK Axis
Open Access
- 8 November 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (11), e80076
- https://doi.org/10.1371/journal.pone.0080076
Abstract
Non-melanoma skin cancer (NMSC) is the most common type of skin cancer in Caucasian populations. Its increasing incidence has been a major public health concern. Elevated expressions of ODC and COX-2 are associated with both murine and human NMSCs. Inhibition of these molecular targets singly employing their respective small molecule inhibitors showed limited success. Here, we show that combined blockade of ODC and COX-2 using their potent inhibitors, DFMO and diclofenac respectively abrogates growth of A431 epidermal xenograft tumors in nu/nu mice by more than 90%. The tumor growth inhibition was associated with a diminution in the proliferation and enhancement in apoptosis. The proliferation markers such as PCNA and cyclin D1 were reduced. TUNEL-positive apoptotic cells and cleaved caspase-3 were increased in the residual tumors. These agents also manifested direct target-unrelated effects. Reduced expression of phosphorylated MAPKAP-2, ERK, and Akt (ser473 & thr308) were noticed. The mechanism by which combined inhibition of ODC/COX attenuated tumor growth and invasion involved reduction in EMT. Akt activation by ODC+COX-2 over-expression was the key player in this regard as Akt inhibition manifested effects similar to those observed by the combined inhibition of ODC+COX-2 whereas forced over-expression of Akt resisted against DFMO+diclofenac treatment. These data suggest that ODC+COX-2 over-expression together leads to pathogenesis of aggressive and invasive cutaneous carcinomas by activating Akt signaling pathway, which through augmenting EMT contributes to tumor invasion.Keywords
This publication has 46 references indexed in Scilit:
- Combined inhibition of p38 and Akt signaling pathways abrogates cyclosporine A-mediated pathogenesis of aggressive skin SCCsBiochemical and Biophysical Research Communications, 2012
- A prolonged and exaggerated wound response with elevated ODC activity mimics early tumor developmentCarcinogenesis: Integrative Cancer Research, 2011
- Chemoprevention of Nonmelanoma Skin Cancer With Celecoxib: A Randomized, Double-Blind, Placebo-Controlled TrialJNCI Journal of the National Cancer Institute, 2010
- Oral Feeding of Pomegranate Fruit Extract Inhibits Early Biomarkers of UVB Radiation‐induced Carcinogenesis in SKH‐1 Hairless Mouse EpidermisPhotochemistry and Photobiology, 2010
- A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin CancerCancer Prevention Research, 2010
- Ornithine Decarboxylase Inhibition by α-Difluoromethylornithine Activates Opposing Signaling Pathways via Phosphorylation of Both Akt/Protein Kinase B and p27Kip1 in NeuroblastomaCancer Research, 2008
- Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF- through a PGE2-dependent mechanismsCarcinogenesis: Integrative Cancer Research, 2008
- Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind TrialCancer Prevention Research, 2008
- Polyamines and nonmelanoma skin cancerToxicology and Applied Pharmacology, 2006
- PI3K/Akt and apoptosis: size mattersOncogene, 2003